Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Mayne Pharma Group (MAYNF)
OTHER OTC:MAYNF
Holding MAYNF?
Track your performance easily
MAYNF Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$1.66 - $5.02
Previous Close$2.54
Volume5.00
Average Volume (3M)3.76K
Market Cap
$258.87M
Enterprise Value$466.36M
Total Cash (Recent Filing)AU$96.67M
Total Debt (Recent Filing)AU$413.67M
Price to Earnings (P/E)―
Beta0.35
Next Earnings
Feb 20, 2025EPS Estimate
-$0.09Last Dividend Ex-Date
Jan 18, 2023Dividend YieldN/A
Share Statistics
EPS (TTM)-1.41
Shares OutstandingN/A
10 Day Avg. Volume131
30 Day Avg. Volume3,760
Standard Deviation0.18
R-Squared0.30
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.03
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4.66Price Target Upside83.46% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Mayne Pharma Group News
PremiumCompany Announcements
Mayne Pharma Issues New Employee Performance Rights
PremiumCompany Announcements
Mayne Pharma Announces Performance Rights Cessation
PremiumCompany Announcements
Mayne Pharma CEO to Speak at Global Investment Conference
PremiumCompany Announcements
Mayne Pharma Director Adjusts Stake
PremiumCompany Announcements
Mayne Pharma Issues New Shares in Expansion Move
PremiumCompany Announcements
Mayne Pharma Announces Performance Rights CessationPremiumCompany Announcements
Mayne Pharma Unveils FY24 Financial InsightsPremiumCompany Announcements
Mayne Pharma’s Stellar Financial Turnaround in FY24MAYNF FAQ
What was Mayne Pharma Group’s price range in the past 12 months?
Mayne Pharma Group lowest stock price was $1.66 and its highest was $5.02 in the past 12 months.
What is Mayne Pharma Group’s market cap?
Currently, no data Available
When is Mayne Pharma Group’s upcoming earnings report date?
Mayne Pharma Group’s upcoming earnings report date is Feb 20, 2025 which is in 153 days.
How were Mayne Pharma Group’s earnings last quarter?
Mayne Pharma Group released its earnings results on Aug 22, 2024. The company reported <$0.001 earnings per share for the quarter, beating the consensus estimate of -$0.15 by $0.15.
Is Mayne Pharma Group overvalued?
According to Wall Street analysts Mayne Pharma Group’s price is currently Undervalued.
Does Mayne Pharma Group pay dividends?
Mayne Pharma Group pays a Notavailable dividend of $0.02 which represents an annual dividend yield of N/A. See more information on Mayne Pharma Group dividends here
What is Mayne Pharma Group’s EPS estimate?
Mayne Pharma Group’s EPS estimate is -$0.09.
How many shares outstanding does Mayne Pharma Group have?
Mayne Pharma Group has 85,074,290 shares outstanding.
What happened to Mayne Pharma Group’s price movement after its last earnings report?
Mayne Pharma Group reported an EPS of <$0.001 in its last earnings report, beating expectations of -$0.15. Following the earnings report the stock price went up 11.364%.
Which hedge fund is a major shareholder of Mayne Pharma Group?
Currently, no hedge funds are holding shares in MAYNF
---
Mayne Pharma Group Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$4.66 (83.46% Upside)
$4.66 (83.46% Upside)
Blogger Sentiment
Bullish
MAYNF Sentiment 82%
Sector Average 71%
Sector Average 71%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
16.24%
12-Months-Change
Fundamentals
Return on Equity
-30.48%
Trailing 12-Months
Asset Growth
-8.10%
Trailing 12-Months
Company Description
Mayne Pharma Group
Mayne Pharma Group Ltd. engages in the development and manufacture of proprietary and generic products. It operates through the following segments: Generic Products, Specialty Brands, Metrics Contract Services, and Mayne Pharma International. The Generic Products segment involves in the manufacture and distribution of generic and branded pharmaceutical products. The Metrics Contract Services segment provides contract pharmaceutical services. The Specialty brands segments includes the distribution of branded pharmaceutical products. The Mayne Pharma International segment offers manufacturing and selling of branded and generic pharmaceutical products and provides contract manufacturing services to third party customers within Australia. The company was founded in 1845 and is headquartered in Salisbury, Australia.
---
MAYNF Stock 12 Month Forecast
Average Price Target
$4.66
▲(83.46% Upside)
Technical Analysis
Best Analysts Covering MAYNF
1 Year
1 Year Success Rate
4/12 ratings generated profit
1 Year Average Return
-13.71%
reiterated a buy rating 28 days ago
Copying Melissa Benson's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -13.71% per trade.
---